VEGFC and atherosclerosis: Similarly, stimulation of endogenous lymphangiogenesis with VEGF‐C156S reduces myocardial inflammation and cardiac dysfunction after I/R injury,19 and administration of VEGF‐C via a local injection in Apo E−/− mice can enhance lymphatic function and reduce the accumulation of cholesterol, which further suppresses atherosclerosis development.51